How to Compete for $4 Billion in Newly Reauthorized SBIR/STTR Funds

​The recent reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program introduces exciting new opportunities along with evolving requirements and shifting priorities. For innovators aiming to compete successfully in this new SBIR/STTR landscape, a thorough understanding of the reauthorization provisions is essential. Join Eva Garland Consulting's Scientific Grants Expert, Dr. Chelcie Heaney, as she provides a practical overview of the latest SBIR/STTR reauthorization and what it means for applicants targeting the National Institutes of Health and National Science Foundation. Attendees will gain insight into key program updates, emerging compliance considerations, and an expert perspective on how to remain competitive in one of the nation’s most valuable non-dilutive funding programs. Lunch will be provided, and attendees will receive complimentary copies of EGC’s best-selling books on winning SBIR/STTR grants.

​About Dr. Chelcie Heaney:

​Dr. Heaney is a Senior Scientific Consultant at Eva Garland Consulting.  She is an expert in securing non-dilutive funding for life science companies, with a focus in technology assessment, product development, proposal preparation, gap identification, and strategic planning. She has contributed to hundreds of grant proposals across Federal Agencies including NIH, NSF, DoD, NASA, ARPA-H, and the VA, helping to secure over $100M in funding for life science companies.